Key Finding
Buccal acupuncture demonstrated superior pain relief with a large effect size (SMD=-1.51) and 54% fewer adverse reactions compared to conventional treatments across 40 randomized controlled trials.
Researchers conducted a comprehensive review of 40 studies involving 3,009 patients to evaluate whether buccal acupuncture—a technique that targets specific points inside the mouth—is effective and safe for managing pain. They searched major medical databases for randomized controlled trials comparing buccal acupuncture to standard treatments like conventional acupuncture or pain medications. The results showed promising benefits for this specialized approach. Patients who received buccal acupuncture experienced significantly better pain relief compared to control groups, with Visual Analogue Scale scores showing substantial improvement. The treatment also demonstrated an impressive safety profile: people receiving buccal acupuncture had 54% fewer adverse reactions than those receiving conventional treatments. Additionally, the overall effectiveness rate was 19% higher in the buccal acupuncture group. These findings suggest that buccal acupuncture may offer advantages over traditional pain management approaches, providing superior pain reduction with fewer side effects. The technique appears particularly valuable as a complementary therapy alongside conventional pain treatments. However, the researchers noted that while these results are encouraging, the quality of existing studies varies, and more rigorous, large-scale clinical trials are needed to confirm these benefits. For patients struggling with chronic pain who haven't found adequate relief with current treatments, buccal acupuncture represents a potentially safer alternative worth discussing with healthcare providers. If you're considering buccal acupuncture for pain management, consult with a licensed acupuncturist trained in specialized oral cavity techniques.
This systematic review and meta-analysis evaluated buccal acupuncture (BA) efficacy for pain management across 40 RCTs encompassing 3,009 patients. Studies were identified through comprehensive database searches through January 2025, with methodological quality assessed using the Cochrane Risk of Bias Tool. Meta-analysis demonstrated significant advantages for BA compared to control interventions: total effective rate RR=1.19 (95% CI: 1.13-1.24, p<0.00001), reduced adverse reaction incidence RR=0.46 (95% CI: 0.37-0.57, p<0.00001), and superior VAS scores SMD=-1.51 (95% CI: -1.98 to -1.04, p<0.00001). The standardized mean difference of -1.51 for pain intensity represents a large effect size, indicating clinically meaningful pain reduction. BA appears advantageous over conventional acupuncture and pharmacotherapy regarding safety profile and analgesic efficacy. Clinical applications include adjunctive pain management, though authors emphasize the need for higher-quality, adequately powered RCTs to validate these findings before widespread clinical implementation.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 A 6-week integrative Korean medicine treatment centered on high-dose Angelica gigas produced clinically significant improvements in pain, function, and quality of life in a patient with 10-year treatment-refractory fibromyalgia unresponsive to opioid therapy.
📌 SSRIs significantly reduced pain and depression in fibromyalgia compared to placebo, but showed no significant advantage over non-pharmacological interventions including acupuncture for treating depression.
📌 Left-sided auricular vagus nerve stimulation reduced pro-inflammatory cytokines and increased anti-inflammatory markers and BDNF in women with fibromyalgia, despite not producing superior pain relief compared to sham treatment.